Publication:
Bioactivity Screening and Gene-Trait Matching across Marine Sponge-Associated Bacteria.

dc.contributor.authorGavriilidou, Asimenia
dc.contributor.authorMackenzie, Thomas Andrew
dc.contributor.authorSánchez, Pilar
dc.contributor.authorTormo, José Ruben
dc.contributor.authorIngham, Colin
dc.contributor.authorSmidt, Hauke
dc.contributor.authorSipkema, Detmer
dc.date.accessioned2023-02-09T10:41:57Z
dc.date.available2023-02-09T10:41:57Z
dc.date.issued2021-01-30
dc.description.abstractMarine sponges harbor diverse microbial communities that represent a significant source of natural products. In the present study, extracts of 21 sponge-associated bacteria were screened for their antimicrobial and anticancer activity, and their genomes were mined for secondary metabolite biosynthetic gene clusters (BGCs). Phylogenetic analysis assigned the strains to four major phyla in the sponge microbiome, namely Proteobacteria, Actinobacteria, Bacteroidetes, and Firmicutes. Bioassays identified one extract with anti-methicillin-resistant Staphylococcus aureus (MRSA) activity, and more than 70% of the total extracts had a moderate to high cytotoxicity. The most active extracts were derived from the Proteobacteria and Actinobacteria, prominent for producing bioactive substances. The strong bioactivity potential of the aforementioned strains was also evident in the abundance of BGCs, which encoded mainly beta-lactones, bacteriocins, non-ribosomal peptide synthetases (NRPS), terpenes, and siderophores. Gene-trait matching was performed for the most active strains, aiming at linking their biosynthetic potential with the experimental results. Genetic associations were established for the anti-MRSA and cytotoxic phenotypes based on the similarity of the detected BGCs with BGCs encoding natural products with known bioactivity. Overall, our study highlights the significance of combining in vitro and in silico approaches in the search of novel natural products of pharmaceutical interest.
dc.identifier.doi10.3390/md19020075
dc.identifier.essn1660-3397
dc.identifier.pmcPMC7912018
dc.identifier.pmid33573261
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912018/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/1660-3397/19/2/75/pdf
dc.identifier.urihttp://hdl.handle.net/10668/17159
dc.issue.number2
dc.journal.titleMarine drugs
dc.journal.titleabbreviationMar Drugs
dc.language.isoen
dc.organizationFundación MEDINA (Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía)
dc.organizationFundación MEDINA
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectantibacterial
dc.subjectanticancer
dc.subjectbiosynthetic gene clusters
dc.subjectgene-trait matching
dc.subjectsponge-associated bacteria
dc.subject.meshAnimals
dc.subject.meshAnti-Infective Agents
dc.subject.meshAntineoplastic Agents
dc.subject.meshBacteria
dc.subject.meshDrug Evaluation, Preclinical
dc.subject.meshGenome, Bacterial
dc.subject.meshMultigene Family
dc.subject.meshPhylogeny
dc.subject.meshPorifera
dc.titleBioactivity Screening and Gene-Trait Matching across Marine Sponge-Associated Bacteria.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number19
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC7912018.pdf
Size:
855.29 KB
Format:
Adobe Portable Document Format